Neutral Recommendation Issued On NTLA By Bank of America Securities
Source: KlickAnalytics
2026-03-02 12:15:06 ET
Historical Analyst Recommendations
Latest 1 ...Full story available on KlickAnalytics.com
Intellia Therapeutics Inc.
NASDAQ: NTLA
NTLA Trading
7.4% G/L:
$13.94 Last:
1,693,485 Volume:
$13.25 Open:
NTLA Latest News
March 03, 2026 07:30:00 am
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
March 02, 2026 07:30:00 am
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
NTLA Stock Data
$1,420,074,893
112,239,198
1.45%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
